Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

MDV-3100 displays safety and antitumor activity in phase I/II trial for prostate cancer

March 6, 2009

MMI presents update on clinical development of GVX-3322 and ONCO-4417

March 6, 2009

BIBF-1120 and BIBW-2992 may be used in combination in prostate cancer treatment

March 6, 2009

Combination of YM-155, docetaxel and prednisone used in prostate cancer therapy

March 6, 2009

Recent Georgia Tech patent describes novel HDAC inhibitors

March 6, 2009

FDA accepts IND application for Tigris Pharmaceutical's GGTI-2418

March 5, 2009

AV-951 shows activity in phase II trial for renal cell carcinoma

March 5, 2009

AZD-4877 shows antitumor activity in human bladder cancer models

March 5, 2009

Gemin X initiates phase II obatoclax trial in combination with chemotherapy

March 5, 2009

AstraZeneca discloses new mTOR inhibitors

March 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...